These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38657794)

  • 1. Plasma Steroid Profiling Combined With Machine Learning for the Differential Diagnosis in Mild Autonomous Cortisol Secretion From Nonfunctioning Adenoma in Patients With Adrenal Incidentalomas.
    Mu D; Qian X; Ma Y; Wang X; Gao Y; Ma X; Xie S; Hou L; Zhang Q; Zhao F; Xia L; Lin L; Qiu L; Wu J; Yu S; Cheng X
    Endocr Pract; 2024 Jul; 30(7):647-656. PubMed ID: 38657794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel model using leukocytes to differentiating mild autonomous cortisol secretion and non-functioning adrenal adenoma.
    Zhao X; Zhou J; Lyu X; Li Y; Ma L; Liu Y; Fan H; Zhang Y
    Sci Rep; 2024 Oct; 14(1):23557. PubMed ID: 39384846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
    Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study.
    Rahimi L; Kittithaworn A; Gregg Garcia R; Saini J; Dogra P; Atkinson EJ; Achenbach SJ; Kattah A; Bancos I
    J Clin Endocrinol Metab; 2024 Aug; 109(9):e1750-e1758. PubMed ID: 38157409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
    Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
    Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea.
    Ku EJ; Lee C; Shim J; Lee S; Kim KA; Kim SW; Rhee Y; Kim HJ; Lim JS; Chung CH; Chun SW; Yoo SJ; Ryu OH; Cho HC; Hong AR; Ahn CH; Kim JH; Choi MH
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1131-1141. PubMed ID: 34674508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Risk Markers in Adults With Adrenal Incidentaloma and Mild Autonomous Cortisol Secretion.
    Chen AX; Radhakutty A; Drake SM; Kiu A; Thompson CH; Burt MG
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1020-e1028. PubMed ID: 37967229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent activities of 21-hydroxylase, 17alpha-hydroxylase and 17,20-lyase are impaired in adrenal incidentalomas.
    Sadoul JL; Kézachian B; Altare S; Hadjali Y; Canivet B
    Eur J Endocrinol; 1999 Sep; 141(3):238-45. PubMed ID: 10474121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC; Mitty HA; Gabrilove JL
    J Urol; 1988 Jul; 140(1):11-5. PubMed ID: 2967899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study.
    Zavatta G; Vicennati V; Altieri P; Tucci L; Colombin G; Coscia K; Mosconi C; Balacchi C; Fanelli F; Malagrinò M; Magagnoli M; Golfieri R; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2023 Apr; 188(4):343-352. PubMed ID: 36952249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral steroid profiling of adrenal cortisol-producing adenomas by liquid chromatography- mass spectrometry.
    Teuber JP; Nanba K; Turcu AF; Chen X; Zhao L; Else T; Auchus RJ; Rainey WE; Rege J
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105924. PubMed ID: 34089832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Steroid Profiling Between Patients With and Without Diabetes Mellitus in Nonfunctioning Adrenal Incidentalomas.
    Nakano Y; Yokomoto-Umakoshi M; Nakatani K; Umakoshi H; Nakao H; Fujita M; Kaneko H; Iwahashi N; Ogasawara T; Fukumoto T; Matsuda Y; Sakamoto R; Izumi Y; Bamba T; Ogawa Y
    J Endocr Soc; 2024 Jul; 8(9):bvae140. PubMed ID: 39145114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
    Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid secretory characteristics of a virilizing adrenal adenoma in a woman.
    Bradshaw KD; Milewich L; Mason JI; Parker CR; MacDonald PC; Carr BR
    J Endocrinol; 1994 Feb; 140(2):297-307. PubMed ID: 8169562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma.
    Zhang LX; Gu WJ; Li YJ; Wang Y; Wang WB; Wang AP; Shen L; Zang L; Yang GQ; Lu ZH; Dou JT; Mu YM
    Am J Hypertens; 2016 May; 29(5):575-81. PubMed ID: 26304960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.